{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T22:04:53Z","timestamp":1765231493038},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1038\/sj.eye.6700257","type":"journal-article","created":{"date-parts":[[2003,2,11]],"date-time":"2003-02-11T14:25:52Z","timestamp":1044973552000},"page":"41-46","source":"Crossref","is-referenced-by-count":36,"title":["The efficacy and safety of the timolol\/dorzolamide fixed combination vs latanoprost in exfoliation glaucoma"],"prefix":"10.1038","volume":"17","author":[{"given":"A G P","family":"Konstas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V P","family":"Kozobolis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I","family":"Tersis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Leech","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W C","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2003,1,23]]},"reference":[{"key":"BF6700257_CR1","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0039-6257(00)00196-X","volume":"45","author":"R Ritch","year":"2001","unstructured":"Ritch R, Schl\u00f6tzer-Schrehardt U . Exfoliation syndrome. Surv Ophthalmol 2001; 45: 265\u2013315.","journal-title":"Surv Ophthalmol"},{"key":"BF6700257_CR2","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/S1350-9462(99)00019-1","volume":"19","author":"E Vesti","year":"2000","unstructured":"Vesti E, Kivela T . Exfoliation syndrome and exfoliation glaucoma. Prog Retin Eye Res 2000; 19: 345\u2013368.","journal-title":"Prog Retin Eye Res"},{"key":"BF6700257_CR3","first-page":"S665","volume":"40","author":"R Fechtner","year":"1999","unstructured":"Fechtner R, Clineschmidt C, Getson A, Adamsons I . A three month, parallel, randomized, observer-masked, multicenter study comparing Cosopt\u2122 to Xalatan\u2122 in patients with elevated IOP. Invest Ophthalmol Vis Sci 1999; 40: S665.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6700257_CR4","first-page":"S420","volume":"42","author":"AGP Konstas","year":"2001","unstructured":"Konstas AGP, Papapanos P, Tersis I, Houliara D, Holmes KT, Stewart WC . A comparison of the efficacy and safety of latanoprost 0.005% every evening versus timolol\/dorzolamide fixed combination twice daily. Invest Ophthalmol Vis Sci 2001; 42: S420.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6700257_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0002-9394(99)00073-2","volume":"128","author":"AGP Konstas","year":"1999","unstructured":"Konstas AGP, Maltezos AC, Gandi S, Hudgins AC, Stewart WC . Comparison of the 24 hour intraocular pressure reduction with two dosing regimes of latanoprost and timolol in patients with open-angle glaucoma. Am J Ophthalmol 1999; 128: 15\u201320.","journal-title":"Am J Ophthalmol"},{"key":"BF6700257_CR6","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1001\/archopht.1997.01100150184006","volume":"115","author":"AGP Konstas","year":"1997","unstructured":"Konstas AGP, Mantziris DA, Stewart WC . Diurnal intraocular pressure in untreated exfoliation and primary open-angle glaucoma. Arch Ophthalmol 1997; 115: 182\u2013185.","journal-title":"Arch Ophthalmol"},{"key":"BF6700257_CR7","first-page":"S1099","volume":"37","author":"R Vogel","year":"1996","unstructured":"Vogel R . The impact of entry criteria on the baseline IOP in glaucoma studies: a meta-analysis. Invest Ophthalmol Vis Sci 1996; 37: S1099.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6700257_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0161-6420(93)31596-4","volume":"100","author":"AGP Konstas","year":"1993","unstructured":"Konstas AGP, Jay JL, Marshall GE, Lee WR . Prevalence, diagnostic features, and response to trabeculectomy in exfoliation glaucoma. Ophthalmology 1993; 100: 619\u2013627.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR9","volume-title":"Essentials of Statistics","author":"SA Book","year":"1978","unstructured":"Book SA . Essentials of Statistics. McGraw-Hill: New York, 1978."},{"key":"BF6700257_CR10","volume-title":"Non Parametric Statistics. Series in Psychology","author":"S Siegel","year":"1956","unstructured":"Siegel S . Non Parametric Statistics. Series in Psychology. McGraw-Hill: New York, 1956."},{"key":"BF6700257_CR11","first-page":"1134","volume":"42","author":"JW Stjernschantz","year":"2001","unstructured":"Stjernschantz JW . From PGF(2alpha)-isopropyl ester to latanoprost: a review of the development of xalatan: the Proctor Lecture. Invest Ophthalmol Vis Sci 2001; 42: 1134\u20131145.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BF6700257_CR12","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0014-4835(89)90011-0","volume":"48","author":"SFE Nilsson","year":"1989","unstructured":"Nilsson SFE, Samuelsson M, Bill A, Stjernschantz J . Increased uveoscleral outflow as a possible mechanism of ocular hypotension caused by prostaglandin F2a-1-isopropylester in the cynomolgus monkey. Exp Eye Res 1989; 48: 707\u2013716.","journal-title":"Exp Eye Res"},{"key":"BF6700257_CR13","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/0014-4835(89)90049-3","volume":"49","author":"BT Gabelt","year":"1989","unstructured":"Gabelt BT, Kaufman PL . Prostaglandin F2a increases uveoscleral outflow in the cynomolgus monkey. Exp Eye Res 1989; 49: 389\u2013402.","journal-title":"Exp Eye Res"},{"key":"BF6700257_CR14","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0002-9394(88)90117-1","volume":"105","author":"JR Kerstetter","year":"1988","unstructured":"Kerstetter JR, Brubaker RF, Wilson SE, Kullerstrand LJ . Prostaglandin F2a-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow. Am J Ophthalmol 1988; 105: 30\u201334.","journal-title":"Am J Ophthalmol"},{"key":"BF6700257_CR15","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1016\/S0161-6420(93)31484-3","volume":"100","author":"CB Toris","year":"1993","unstructured":"Toris CB, Camras CD, Yablonski ME . Effects of PhXA41, a new prostaglandin F2a analog, on aqueous humor dynamics in human eyes. Ophthalmology 1993; 100: 1297\u20131304.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR16","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1016\/S0161-6420(95)30798-1","volume":"102","author":"A Alm","year":"1995","unstructured":"Alm A, Stjernschantz J, Scandinavian Latanoprost Study Group. Effects on intraocular pressure and side effects of 0.005% latanoprost applied once daily, evening or morning: a comparison with timolol. Ophthalmology 1995; 102: 1743\u20131752.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR17","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/S0161-6420(96)30749-5","volume":"103","author":"CB Camras","year":"1996","unstructured":"Camras CB, United States Latanoprost Study Group. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: a six-month, masked, multicenter trial in the United States. Ophthalmology 1996; 103: 138\u2013147.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR18","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/S0161-6420(96)30750-1","volume":"103","author":"P Watson","year":"1996","unstructured":"Watson P, Stjernschantz J, Scandinavian Latanoprost Study Group. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. Ophthalmology 1996; 103: 126\u2013137.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR19","first-page":"1","volume-title":"Current and Future Glaucoma Therapy","author":"WC Stewart","year":"1997","unstructured":"Stewart WC . Current and Future Glaucoma Therapy, Ciba Vision Ophthalmics: Duluth, GA, 1997, pp 1\u201343."},{"key":"BF6700257_CR20","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1034\/j.1600-0420.1999.770612.x","volume":"77","author":"SL Smith","year":"1999","unstructured":"Smith SL, Pruitt CA, Sine CS, Hudgins AC, Stewart WC . Latanoprost 0.005% and anterior segment uveitis. Acta Ophthalmol Scand 1999; 77: 668\u2013672.","journal-title":"Acta Ophthalmol Scand"},{"key":"BF6700257_CR21","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/S0161-6420(99)00528-X","volume":"106","author":"SE Moroi","year":"1999","unstructured":"Moroi SE, Gottfredsdottir MS, Schteingart MT, Elner SG, Lee CM, Schertzer RM et al.. Cystoid macular edema associated with latanoprost therapy in a case series of patients with glaucoma and ocular hypertension. Ophthalmology 1999; 106: 1024\u20131029.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/S0002-9394(99)00089-6","volume":"127","author":"HE Kaufman","year":"1999","unstructured":"Kaufman HE, Varnell ED, Thompson HW . Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol 1999; 127: 531\u2013536.","journal-title":"Am J Ophthalmol"},{"key":"BF6700257_CR23","first-page":"142","volume":"127","author":"WC Stewart","year":"1999","unstructured":"Stewart WC . New perspectives in the medical treatment of glaucoma. Curr Opin Ophthalmol 1999; 127: 142\u2013147.","journal-title":"Curr Opin Ophthalmol"},{"key":"BF6700257_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0161-6420(98)91046-6","volume":"105","author":"JE Boyle","year":"1998","unstructured":"Boyle JE, Ghosh K, Gieser DK, Adamsons IA, Dorzolamide\u2013Timolol Study Group. A randomized trial comparing the dorzolamide\u2013timolol combination given twice daily to monotherapy with timolol and dorzolamide. Ophthalmology 1998; 105: 145\u2013151.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR25","first-page":"17","volume":"106","author":"CM Clineshmidt","year":"1999","unstructured":"Clineshmidt CM, Williams RD, Snyder E, Adamsons IA . A randomized trial in patients inadequately controlled on timolol alone comparing the dorzolamide\u2013timolol combination to monotherapy with timolol or dorzolamide. Ophthalmology 1999; 106: 17\u201324.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR26","first-page":"10","volume":"106","author":"JE Boyle","year":"1999","unstructured":"Boyle JE, Ghosh K, Gieser DK, Adamsons IA . A randomized trial comparing the dorzolamide\u2013timolol combination given twice daily to monotherapy with timolol or dorzolamide. Ophthalmology 1999; 106: 10\u201316.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR27","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1136\/bjo.82.11.1249","volume":"82","author":"J Hutzelmann","year":"1998","unstructured":"Hutzelmann J, Owens S, Sedden A, Adamsons I, Vargas E . Comparison of the safety and efficacy of the fixed combination of dorzolamide\/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group. Br J Ophthalmol 1998; 82: 1249\u20131253.","journal-title":"Br J Ophthalmol"},{"key":"BF6700257_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1001\/archinte.158.3.221","volume":"158","author":"WC Stewart","year":"1998","unstructured":"Stewart WC, Garrison PM . \u03b2-blocker-induced complications and the glaucoma patient: newer treatments to help reduce systemic side effects. Arch Int Med 1998; 158: 221\u2013226.","journal-title":"Arch Int Med"},{"key":"BF6700257_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/S0161-6420(97)30348-0","volume":"104","author":"A Heijl","year":"1997","unstructured":"Heijl A, Strahlman E, Sverrisson T et al. A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension. Ophthalmology 1997; 104: 137\u2013142.","journal-title":"Ophthalmology"},{"key":"BF6700257_CR30","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/eye.2000.16","volume":"14","author":"AGP Konstas","year":"2000","unstructured":"Konstas AGP, Maltezos T, Bufidis T, Hudgins AC, Stewart WC . 24 hour control of IOP with dorzolamide and timolol maleate in exfoliation and primary open-angle glaucoma. Eye 2000; 14: 73\u201377.","journal-title":"Eye"},{"key":"BF6700257_CR31","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/eye.2001.14","volume":"15","author":"AGP Konstas","year":"2001","unstructured":"Konstas AGP, Lake S, Maltezos AC, Holmes KT, Stewart WC . 24 hour intraocular pressure reduction with latanoprost compared to pilocarpine as third line therapy in exfoliation glaucoma. Eye 2001; 15: 59\u201362.","journal-title":"Eye"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/6700257.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6700257","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/6700257.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T12:10:48Z","timestamp":1684411848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/6700257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["BF6700257"],"URL":"https:\/\/doi.org\/10.1038\/sj.eye.6700257","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}